These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32160948)

  • 1. Rotavirus specific maternal antibodies and immune response to RV3-BB rotavirus vaccine in central java and yogyakarta, Indonesia.
    Danchin MH; Bines JE; Watts E; Cowley D; Pavlic D; Lee KJ; Huque H; Kirkwood C; Nirwati H; At Thobari J; Dewi Satria C; Soenarto Y; Oktaria V
    Vaccine; 2020 Apr; 38(16):3235-3242. PubMed ID: 32160948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.
    Chen MY; Kirkwood CD; Bines J; Cowley D; Pavlic D; Lee KJ; Orsini F; Watts E; Barnes G; Danchin M
    Hum Vaccin Immunother; 2017 May; 13(5):1126-1135. PubMed ID: 28059609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study.
    Witte D; Handley A; Jere KC; Bogandovic-Sakran N; Mpakiza A; Turner A; Pavlic D; Boniface K; Mandolo J; Ong DS; Bonnici R; Justice F; Bar-Zeev N; Iturriza-Gomara M; Ackland J; Donato CM; Cowley D; Barnes G; Cunliffe NA; Bines JE
    Lancet Infect Dis; 2022 May; 22(5):668-678. PubMed ID: 35065683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial.
    Bines JE; Danchin M; Jackson P; Handley A; Watts E; Lee KJ; West A; Cowley D; Chen MY; Barnes GL; Justice F; Buttery JP; Carlin JB; Bishop RF; Taylor B; Kirkwood CD;
    Lancet Infect Dis; 2015 Dec; 15(12):1389-97. PubMed ID: 26318715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB).
    Cowley D; Sari RM; Handley A; Watts E; Bachtiar NS; At Thobari J; Satria CD; Bogdanovic-Sakran N; Nirwati H; Orsini F; Lee KJ; Kirkwood CD; Soenarto Y; Bines JE
    Vaccine; 2019 Nov; 37(49):7233-7239. PubMed ID: 31607604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine.
    Danchin M; Kirkwood CD; Lee KJ; Bishop RF; Watts E; Justice FA; Clifford V; Cowley D; Buttery JP; Bines JE
    Vaccine; 2013 May; 31(23):2610-6. PubMed ID: 23597719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.
    Bines JE; At Thobari J; Satria CD; Handley A; Watts E; Cowley D; Nirwati H; Ackland J; Standish J; Justice F; Byars G; Lee KJ; Barnes GL; Bachtiar NS; Viska Icanervilia A; Boniface K; Bogdanovic-Sakran N; Pavlic D; Bishop RF; Kirkwood CD; Buttery JP; Soenarto Y
    N Engl J Med; 2018 Feb; 378(8):719-730. PubMed ID: 29466164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.
    Cowley D; Boniface K; Bogdanovic-Sakran N; Kirkwood CD; Bines JE
    Hum Vaccin Immunother; 2017 Aug; 13(8):1908-1915. PubMed ID: 28481726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of human neonatal RV3 rotavirus vaccine (Bio Farma) in adults, children, and neonates in Indonesia: Phase I Trial.
    At Thobari J; Damayanti W; Haposan JH; Nirwati H; Iskandar K; Samad ; Fahmi J; Sari RM; Bachtiar NS; Watts E; Bines JE; Soenarto Y
    Vaccine; 2021 Jul; 39(33):4651-4658. PubMed ID: 34244006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine.
    Cowley D; Pavlic D; Bogdanovic-Sakran N; Boniface K; Kirkwood CD; Bines JE
    Hum Vaccin Immunother; 2018; 14(8):2082-2087. PubMed ID: 29688121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia.
    Cowley D; Nirwati H; Donato CM; Bogdanovic-Sakran N; Boniface K; Kirkwood CD; Bines JE
    Vaccine; 2018 Sep; 36(39):5872-5878. PubMed ID: 30145099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA Status.
    Donato CM; Handley A; Byars SG; Bogdanovic-Sakran N; Lyons EA; Watts E; Ong DS; Pavlic D; At Thobari J; Satria CD; Nirwati H; Soenarto Y; Bines JE
    J Infect Dis; 2024 Apr; 229(4):1010-1018. PubMed ID: 37592804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Neonatal Rotavirus Vaccine (RV3-BB) Produces Vaccine Take Irrespective of Histo-Blood Group Antigen Status.
    Boniface K; Byars SG; Cowley D; Kirkwood CD; Bines JE
    J Infect Dis; 2020 Mar; 221(7):1070-1078. PubMed ID: 31763671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.
    Chilengi R; Simuyandi M; Beach L; Mwila K; Becker-Dreps S; Emperador DM; Velasquez DE; Bosomprah S; Jiang B
    PLoS One; 2016; 11(3):e0150100. PubMed ID: 26974432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants.
    Rongsen-Chandola T; Strand TA; Goyal N; Flem E; Rathore SS; Arya A; Winje BA; Lazarus R; Shanmugasundaram E; Babji S; Sommerfelt H; Vainio K; Kang G; Bhandari N
    Vaccine; 2014 Aug; 32 Suppl 1():A134-9. PubMed ID: 25091668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
    Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
    Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule.
    Geard N; Bradhurst R; Tellioglu N; Oktaria V; McVernon J; Handley A; Bines JE
    Hum Vaccin Immunother; 2022 Nov; 18(6):2139097. PubMed ID: 36409459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries.
    Baker JM; Tate JE; Leon J; Haber MJ; Lopman BA
    PLoS Med; 2019 Dec; 16(12):e1003005. PubMed ID: 31887139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries?
    Chan J; Nirwati H; Triasih R; Bogdanovic-Sakran N; Soenarto Y; Hakimi M; Duke T; Buttery JP; Bines JE; Bishop RF; Kirkwood CD; Danchin MD
    Vaccine; 2011 Feb; 29(6):1242-7. PubMed ID: 21147127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery.
    Kumar P; Pullagurla SR; Patel A; Shukla RS; Bird C; Kumru OS; Hamidi A; Hoeksema F; Yallop C; Bines JE; Joshi SB; Volkin DB
    J Pharm Sci; 2021 Feb; 110(2):760-770. PubMed ID: 33035539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.